These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

192 related articles for article (PubMed ID: 37847018)

  • 1. Non-β Lactam Inhibitors of the Serine β-Lactamase blaCTX-M15 in Drug-Resistant
    Ahmad F; Parvaiz N; MacKerell AD; Azam SS
    J Chem Inf Model; 2023 Nov; 63(21):6681-6695. PubMed ID: 37847018
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Determination of potential combination of non-β-lactam, β-lactam, and β-lactamase inhibitors/β-lactam enhancer against class D oxacillinases producing Acinetobacter baumannii: Evidence from in-vitro, molecular docking and dynamics simulation.
    Gopikrishnan M; Ramireddy S; Varghese RP; Bakathavatchalam YD; D TK; Manesh A; Walia K; Veeraraghavan B; C GPD
    J Cell Biochem; 2023 Jul; 124(7):974-988. PubMed ID: 37282600
    [TBL] [Abstract][Full Text] [Related]  

  • 3. OP0595, a new diazabicyclooctane: mode of action as a serine β-lactamase inhibitor, antibiotic and β-lactam 'enhancer'.
    Morinaka A; Tsutsumi Y; Yamada M; Suzuki K; Watanabe T; Abe T; Furuuchi T; Inamura S; Sakamaki Y; Mitsuhashi N; Ida T; Livermore DM
    J Antimicrob Chemother; 2015 Oct; 70(10):2779-86. PubMed ID: 26089439
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Broad-Spectrum Inhibitors against Class A, B, and C Type β-Lactamases to Block the Hydrolysis against Antibiotics: Kinetics and Structural Characterization.
    Farhat N; Gupta D; Ali A; Kumar Y; Akhtar F; Kulanthaivel S; Mishra P; Khan F; Khan AU
    Microbiol Spectr; 2022 Oct; 10(5):e0045022. PubMed ID: 36069578
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Discovery of beta-lactamase CMY-10 inhibitors for combination therapy against multi-drug resistant Enterobacteriaceae.
    Parvaiz N; Ahmad F; Yu W; MacKerell AD; Azam SS
    PLoS One; 2021; 16(1):e0244967. PubMed ID: 33449932
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Risedronate and Methotrexate Are High-Affinity Inhibitors of New Delhi Metallo-β-Lactamase-1 (NDM-1): A Drug Repurposing Approach.
    Muteeb G; Alsultan A; Farhan M; Aatif M
    Molecules; 2022 Feb; 27(4):. PubMed ID: 35209073
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Computational modelling of potential Zn-sensitive non-β-lactam inhibitors of imipenemase-1 (IMP-1).
    Ayipo YO; Ahmad I; Alananzeh W; Lawal A; Patel H; Mordi MN
    J Biomol Struct Dyn; 2023 Nov; 41(19):10096-10116. PubMed ID: 36476097
    [TBL] [Abstract][Full Text] [Related]  

  • 8. 1,4,7-Triazacyclononane Restores the Activity of β-Lactam Antibiotics against Metallo-β-Lactamase-Producing
    Somboro AM; Amoako DG; Osei Sekyere J; Kumalo HM; Khan R; Bester LA; Essack SY
    Appl Environ Microbiol; 2019 Feb; 85(3):. PubMed ID: 30478231
    [TBL] [Abstract][Full Text] [Related]  

  • 9. β-Lactamases and β-Lactamase Inhibitors in the 21st Century.
    Tooke CL; Hinchliffe P; Bragginton EC; Colenso CK; Hirvonen VHA; Takebayashi Y; Spencer J
    J Mol Biol; 2019 Aug; 431(18):3472-3500. PubMed ID: 30959050
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Molecular basis of the beta-lactamase protein using comparative modelling, drug screening and molecular dynamics studies to understand the resistance of β-lactam antibiotics.
    Alazmi M
    J Mol Model; 2020 Jul; 26(8):200. PubMed ID: 32638150
    [TBL] [Abstract][Full Text] [Related]  

  • 11. High-Throughput Virtual Screening, Molecular Dynamics Simulation, and Enzyme Kinetics Identified ZINC84525623 as a Potential Inhibitor of NDM-1.
    Rehman MT; AlAjmi MF; Hussain A; Rather GM; Khan MA
    Int J Mol Sci; 2019 Feb; 20(4):. PubMed ID: 30769822
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Phenotypic and
    Moreira JS; Galvão DS; Xavier CFC; Cunha S; Pita SSDR; Reis JN; Freitas HF
    J Biomol Struct Dyn; 2022; 40(24):14223-14235. PubMed ID: 34766882
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Probing intermolecular interactions and binding stability of antimicrobial peptides with beta-lactamase of
    Chakkyarath V; Natarajan J
    J Biomol Struct Dyn; 2022; 40(24):13641-13657. PubMed ID: 34676806
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Stigmasterol: An adjuvant for beta lactam antibiotics against beta-lactamase positive clinical isolates.
    Yenn TW; Arslan Khan M; Amiera Syuhada N; Chean Ring L; Ibrahim D; Tan WN
    Steroids; 2017 Dec; 128():68-71. PubMed ID: 29104098
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Biochemical characterization of CTX-M-15 from Enterobacter cloacae and designing a novel non-β-lactam-β-lactamase inhibitor.
    Faheem M; Rehman MT; Danishuddin M; Khan AU
    PLoS One; 2013; 8(2):e56926. PubMed ID: 23437273
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Computational and data mining studies to understand the distribution and dynamics of Temoneria (TEM) β-lactamase and their interaction with β-lactam and β-lactamase inhibitors.
    Gehlot P; P H
    Environ Pollut; 2022 Dec; 314():120289. PubMed ID: 36180000
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Designing of inhibitors against CTX-M-15 type β-lactamase: potential drug candidate against β-lactamases-producing multi-drug-resistant bacteria.
    Ali A; Danishuddin ; Maryam L; Srivastava G; Sharma A; Khan AU
    J Biomol Struct Dyn; 2018 May; 36(7):1806-1821. PubMed ID: 28545327
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of non-β-lactams on stable variants of inhibitor-resistant TEM β-lactamase in uropathogenic Escherichia coli: implication for alternative therapy.
    Mukherjee SK; Mandal RS; Das S; Mukherjee M
    J Appl Microbiol; 2018 Mar; 124(3):667-681. PubMed ID: 29247576
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A computational odyssey: uncovering classical β-lactamase inhibitors in dry fruits.
    Javid A; Ahmed M
    J Biomol Struct Dyn; 2024 Jun; 42(9):4578-4604. PubMed ID: 37288775
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Escape mutations circumvent a tradeoff between resistance to a beta-lactam and resistance to a beta-lactamase inhibitor.
    Russ D; Glaser F; Shaer Tamar E; Yelin I; Baym M; Kelsic ED; Zampaloni C; Haldimann A; Kishony R
    Nat Commun; 2020 Apr; 11(1):2029. PubMed ID: 32332717
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.